- Home
- Publications
- Publication Search
- Publication Details
Title
Sirtuin 1 activator SRT2104 protects Huntington's disease mice
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 1, Issue 12, Pages 1047-1052
Publisher
Wiley
Online
2014-10-31
DOI
10.1002/acn3.135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- SIRT1 in Neurodevelopment and Brain Senescence
- (2014) A. Zara Herskovits et al. NEURON
- Small molecule SIRT1 activators for the treatment of aging and age-related diseases
- (2014) Basil P. Hubbard et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
- (2014) Sarah J. Mitchell et al. Cell Reports
- Molecular architecture of the human protein deacetylase Sirt1 and its regulation by AROS and resveratrol
- (2013) Mahadevan Lakshminarasimhan et al. BIOSCIENCE REPORTS
- Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease
- (2013) M. Jiang et al. HUMAN MOLECULAR GENETICS
- A Dietary Regimen of Caloric Restriction or Pharmacological Activation of SIRT1 to Delay the Onset of Neurodegeneration
- (2013) J. Graff et al. JOURNAL OF NEUROSCIENCE
- The Identification of the SIRT1 Activator SRT2104 as a Clinical Candidate
- (2013) Pui Ng et al. Letters in Drug Design & Discovery
- Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators
- (2013) B. P. Hubbard et al. SCIENCE
- Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
- (2012) Ethan Hoffmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers
- (2012) Vincenzo Libri et al. PLoS One
- Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
- (2011) Mali Jiang et al. NATURE MEDICINE
- Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway
- (2011) Hyunkyung Jeong et al. NATURE MEDICINE
- Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
- (2011) Yong Cheng et al. NEUROIMAGE
- SIRT2 regulates NF- B-dependent gene expression through deacetylation of p65 Lys310
- (2010) K. M. Rothgiesser et al. JOURNAL OF CELL SCIENCE
- SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
- (2010) Ruth Luthi-Carter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now